Geneva, Oct. 21 -- International Clinical Trials Registry received information related to the study (JPRN-jRCT1032250397) titled 'PulseSelect Japan Registry' on Sept. 30.
Study Type: Observational
Primary Sponsor: Sasano Tetsuo
Condition:
Treatment of the drug-resistant and recurrent symptomatic pAF or drug-resistant and symptomatic PsAF
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 30/09/2025
Target Sample Size: 1000
To know more, visit https://jrct.mhlw.go.jp/latest-detail/jRCT1032250397
Published by HT Digital Content Services with permission from Health Daily Digest....